Keith Rubin

Keith Rubin, M.D. is Founder and CEO of ILiAD Biotechnologies and serves on the Executive Board. Prior to ILiAD, Dr. Rubin founded Seedlings Life Science Ventures, a medical technology company that has successfully developed and advanced multiple patented technologies including the out-license of IP for a commercialized auto-injector to treat anaphylaxis. From 1990 to 2000, Dr. Rubin practiced Internal Medicine with a primary focus on the care of patients with HIV and AIDS in New York City and served as Teaching Attending at Beth Israel and Cabrini Medical Centers and St. Vincent’s Hospital. Dr. Rubin has been Assistant Professor of Clinical Medicine at the University of Miami Miller School of Medicine (UM) and New York Medical College, and has held several positions in technology innovation at UM, including Executive Director of BioScience Ventures. He is a graduate of the University of Miami School of Medicine and holds a B.A. in Biology from Princeton University.

Keith Rubin is the Founder and CEO at ILiAD Biotechnologies. With a background in Biotechnology, Keith Rubin has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.